Cannabinoid CB 1 Receptor Activation Mitigates N -Methyl- d -aspartate Receptor-Mediated Neurotoxicity
ACS Pharmacology & Translational Science · 12.09.2025 · 8 (9) · 3019-3032
DOI: 10.1021/acsptsci.5c00230 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 25.08.2025. Verfasst von Gemma Navarro und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CiberNed), National Institute of Health Carlos III, 28031 Madrid, Spain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovaci?n y Universidades, European Regional Development Fund, Generalitat de Catalunya.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CiberNed), National Institute of Health Carlos III, 28031 Madrid, Spain.
- Institut de Neurociències UB, Campus Mundet, 08035 Barcelona, Spain.
- Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Science, University of Barcelona, 08028 Barcelona, Spain.
- Departament de Biochemistry and Molecular Biomedicine, University of Barcelona, 08028 Barcelona, Spain.
- Institut de Neurociències, Department de Bioquímica i Biologia Molecular, Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.
- Departament de Bioquímica i de Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.
ORCID-Profile: Eddy Sotelo, Rafael Franco
Förderung
- Ministerio de Ciencia, Innovaci?n y Universidades
- European Regional Development Fund
- Generalitat de Catalunya
Zitieren
APA
Navarro, G., Raïch, I., Rebassa, J. B., Lillo, J., Pérez-Olives, C., Capó, T., Cubeles, E., Saura, C. A., Cordomí, A., Sotelo, E., Reyes-Resina, I., & Franco, R. (2025). Cannabinoid CB 1 Receptor Activation Mitigates N -Methyl- d -aspartate Receptor-Mediated Neurotoxicity. ACS Pharmacology & Translational Science, 8(9), 3019-3032. https://doi.org/10.1021/acsptsci.5c00230
Vancouver
Navarro G, Raïch I, Rebassa JB, Lillo J, Pérez-Olives C, Capó T, et al. Cannabinoid CB 1 Receptor Activation Mitigates N -Methyl- d -aspartate Receptor-Mediated Neurotoxicity. ACS Pharmacology & Translational Science. 2025;8(9):3019-3032. doi:10.1021/acsptsci.5c00230
BibTeX
@article{Navarro2025,
author = {Navarro, Gemma and Raïch, Iu and Rebassa, Joan Biel and Lillo, Jaume and Pérez-Olives, Catalina and Capó, Toni and Cubeles, Erik and Saura, Carlos A and Cordomí, Arnau and Sotelo, Eddy and Reyes-Resina, Irene and Franco, Rafael},
title = {Cannabinoid CB 1 Receptor Activation Mitigates N -Methyl- d -aspartate Receptor-Mediated Neurotoxicity},
journal = {ACS Pharmacology & Translational Science},
year = {2025},
volume = {8},
number = {9},
pages = {3019--3032},
doi = {10.1021/acsptsci.5c00230}
}
EUVIMED